{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:36:35Z","timestamp":1767922595535,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clinre.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:45:35Z","timestamp":1540007135000},"page":"451-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A meta-analysis of the efficacy and safety of iodine [131I] metuximab infusion combined with TACE for treatment of hepatocellular carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Wenzhe","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2018.09.006_bib0005","first-page":"123","article-title":"Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma","volume":"55","author":"Hussain","year":"2009","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.clinre.2018.09.006_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1259\/bjr\/33521596","article-title":"Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma","volume":"80","author":"Zhou","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clinre.2018.09.006_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460500400407","article-title":"Targeted cancer therapy using radiolabeled monoclonal antibodies","volume":"4","author":"Bethge","year":"2005","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.clinre.2018.09.006_bib0020","first-page":"356","article-title":"A study of anti-human liver cancer monoclonal antibody fragment HAb18(ab\u2019)2 lyophilization processes","volume":"13","author":"Feng","year":"2002","journal-title":"Sheng Wu Ji Shu Tong Xin"},{"key":"10.1016\/j.clinre.2018.09.006_bib0025","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.7314\/APJCP.2015.16.17.7441","article-title":"131I-labeled-metuximab plus transarterial chemoembolization in combination therapy for unresectable hepatocellular carcinoma: results from a multicenter phase IV clinical study","volume":"16","author":"Ma","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clinre.2018.09.006_bib0030","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.3748\/wjg.v19.i47.9104","article-title":"131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma","volume":"19","author":"He","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.09.006_bib0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00259-012-2145-5","article-title":"Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study","volume":"39","author":"Wu","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinre.2018.09.006_bib0040","first-page":"657","article-title":"Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients","volume":"25","author":"Wu","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.clinre.2018.09.006_bib0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinre.2018.09.006_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clinre.2018.09.006_bib0055","first-page":"728","article-title":"Clinical value of treatment of middle- and late-stage liver cancer and postoperative recurrence with 131I metuximab infusion combined with transcatheter arterial chemoembolization","volume":"21","author":"Li","year":"2013","journal-title":"Zhong Hua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.clinre.2018.09.006_bib0060","first-page":"65","article-title":"A study of the efficacy and safety of 76 middle-to-late stage primary liver cancer patients with 131I-metuximab infusion combined with TACE","volume":"1","author":"Yao","year":"2016","journal-title":"Jie Ru Fang She Xue Za Zhi"},{"key":"10.1016\/j.clinre.2018.09.006_bib0065","first-page":"1026","article-title":"An analysis of outcomes of treatment of primary liver cancer with 131I-metuximab infusion combined with TACE","volume":"21","author":"Guo","year":"2011","journal-title":"Zhong Guo Xian Dai Yi Xue Za Zhi"},{"key":"10.1016\/j.clinre.2018.09.006_bib0070","first-page":"649","article-title":"A comparative study of treatment of primary liver cancer with 131I-metuximab infusion combined with transcatheter arterial chemoembolization","volume":"6","author":"Guo","year":"2015","journal-title":"Chengdu Yi Xue Yuan Xue Bao"},{"key":"10.1016\/j.clinre.2018.09.006_bib0075","first-page":"56","article-title":"A clinical study of treatment of primary hepatocellular carcinoma with 131I-metuximab infusion combined with TACE","volume":"51","author":"Dong","year":"2013","journal-title":"Zhong Guo Xian Dai Yi Xue"},{"key":"10.1016\/j.clinre.2018.09.006_bib0080","first-page":"1068","article-title":"Short-term efficacy of treatment of primary hepatocellular carcinoma with 131I-metuximab infusion combined with TACE","volume":"18","author":"Wei","year":"2009","journal-title":"Wu Jing Yi Xue Yuan Xue Bao"},{"key":"10.1016\/j.clinre.2018.09.006_bib0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00270-003-0513-z","article-title":"Percutaneous ethanol injection via an artificially induced right hydrothorax for hepatocellular carcinoma in the hepatic dome","volume":"26","author":"Kume","year":"2003","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.clinre.2018.09.006_bib0090","first-page":"204","article-title":"Effect of transcatheter arterial chemoembolization on liver cancer angiogenesis and vascular endothelial growth factor expression","volume":"39","author":"Wang","year":"2005","journal-title":"Zhong Hua Fang She Xue Za Zhi"},{"key":"10.1016\/j.clinre.2018.09.006_bib0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2005.08.029","article-title":"Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy","volume":"64","author":"Nag","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2018.09.006_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/1541-7786.MCR-06-0286","article-title":"HAb18G\/CD147 functions in invasion and metastasis of hepatocellular carcinoma","volume":"5","author":"Xu","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.clinre.2018.09.006_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2005.12.034","article-title":"Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I\/II trials","volume":"65","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2018.09.006_bib0110","first-page":"857","article-title":"A pharmacokinetic study of 131I-metuximab infusion in the human body","volume":"24","author":"Li","year":"2007","journal-title":"Sheng Wu Yi Xue Gong Cheng Za Zhi"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:28:12Z","timestamp":1761895692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118301888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2210740118301888"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.09.006","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis of the efficacy and safety of iodine [131I] metuximab infusion combined with TACE for treatment of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}